Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$0.8600
-0.17-16.50%
At close: -
$0.8865
0.033.08%
After Hours: 7:22 PM EDT
Comments
Loading...
Biofrontera (BFRI) Forecast
NewsEarningsBiofrontera (BFRI) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Biofrontera Stock Price, Quotes and Forecasts | NASDAQ:BFRI | Benzinga
Explore Biofrontera stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for BFRI.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Biofrontera (BFRI) stock?
You can purchase shares of Biofrontera (NASDAQ:BFRI) through any online brokerage.
Who are Biofrontera (BFRI) competitors?
Other companies in Biofrontera’s space includes: Cingulate (NASDAQ:CING), Gelteq (NASDAQ:GELS), Cocrystal Pharma (NASDAQ:COCP), Addex Therapeutics (NASDAQ:ADXN) and Kiora Pharmaceuticals (NASDAQ:KPRX).
What is the forecast, or price target, for Biofrontera (BFRI) stock?
Biofrontera has a consensus price target of $7.00.
What is the current price for Biofrontera (BFRI)?
The stock price for Biofrontera (NASDAQ: BFRI) is $0.8865 last updated March 21, 2025 at 7:22 PM EDT.
Does Biofrontera (BFRI) pay a dividend?
There are no upcoming dividends for Biofrontera.
When is Biofrontera (NASDAQ:BFRI) reporting earnings?
Biofrontera’s Q1 earnings are confirmed for Wednesday, May 14, 2025.
Is Biofrontera (BFRI) going to split?
There is no upcoming split for Biofrontera.
What sector and industry does Biofrontera (BFRI) operate in?
Biofrontera is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.